Baxter
Baxter International Inc., commonly referred to as Baxter, is a leading global healthcare company headquartered in the United States. Founded in 1931, Baxter has established a strong presence in various operational regions, including North America, Europe, and Asia. The company operates primarily in the medical devices and pharmaceuticals industry, focusing on critical care, renal care, and surgical products. Baxter is renowned for its innovative core products, such as intravenous (IV) solutions, dialysis equipment, and surgical instruments, which are designed to enhance patient outcomes and streamline healthcare delivery. With a commitment to quality and safety, Baxter has achieved significant milestones, including advancements in renal therapies and the development of cutting-edge infusion systems. As a trusted partner in healthcare, Baxter continues to maintain a strong market position, recognised for its dedication to improving patient care worldwide.
DitchCarbon Score
How does Baxter's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Baxter's score of 44 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Baxter's reported carbon emissions
In 2023, Baxter reported total carbon emissions of approximately 4,031,000,000 kg CO2e, with Scope 1 emissions accounting for about 352,000,000 kg CO2e and Scope 2 emissions at approximately 219,000,000 kg CO2e. The company also disclosed significant Scope 3 emissions, totalling around 3,461,000,000 kg CO2e, which includes emissions from capital goods, business travel, and the use of sold products. Baxter has not set specific reduction targets or initiatives as part of its climate commitments, indicating a lack of formalised strategies such as Science-Based Targets Initiative (SBTi) targets or documented reduction initiatives. This absence of defined goals may reflect broader industry challenges in establishing comprehensive climate action plans. Overall, Baxter's emissions data highlights the scale of its carbon footprint, particularly in Scope 3 emissions, which are critical for understanding the full impact of its operations on climate change. The company operates from its headquarters in the US and continues to navigate the complexities of corporate sustainability in the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2002 | 2003 | 2004 | 2005 | 2006 | 2009 | 2010 | 2011 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 781,365,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | - | - | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Baxter is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
